{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:57:04Z","timestamp":1770479824297,"version":"3.49.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[1997,10,1]],"date-time":"1997-10-01T00:00:00Z","timestamp":875664000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,5,18]],"date-time":"2006-05-18T00:00:00Z","timestamp":1147910400000},"content-version":"vor","delay-in-days":3151,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1997,10]]},"DOI":"10.1111\/j.1365-2133.1997.tb03788.x","type":"journal-article","created":{"date-parts":[[2006,5,18]],"date-time":"2006-05-18T08:15:31Z","timestamp":1147940131000},"page":"568-576","source":"Crossref","is-referenced-by-count":145,"title":["A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases:<i>in vivo<\/i>pharmacology"],"prefix":"10.1093","volume":"137","author":[{"given":"J.G.","family":"MEINGASSNER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"GRASSBERGER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"FAHRNGRUBER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.D.","family":"MOORE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"SCHUURMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"ST\u00dcTZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,5,18]]},"reference":[{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB1|cit1","first-page":"19","volume-title":"Psoriasis. The Prevalence in Sex, Age and Occupational Groups in Total Populations in Sweden, Morphology, Inheritance and Association with Other Skin and Rheumatic Diseases","author":"Hellgren","year":"1976"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB2|cit2","first-page":"107","article-title":"Skin disease in Lambeth","volume":"30","author":"Rea","year":"1976","journal-title":"Br J Prevent Social Med"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB3|cit3","unstructured":"US National Health Survey 1971-74 Vital and Health Statistics"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB4|cit4","first-page":"9","article-title":"The epidemiology of atopic dermatitis","volume":"31","author":"Schultz","year":"1993","journal-title":"Monogr Allergy"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB5|cit5","first-page":"9","article-title":"Dermatite atopique de l'enfant","volume":"45","author":"Saurat","year":"1987","journal-title":"Ann Nestle"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02991185","article-title":"Natural history and clinical manifestations of atopic eczema","volume":"4","author":"Rajka","year":"1986","journal-title":"Clin Rev Allergy"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB7|cit7","first-page":"4","article-title":"Prevalence of dermatologic disease among persons 1-74 years of age in the United States","author":"Johnson","year":"1977","journal-title":"Advance Data from Vital and Health Statistics of the National Center for Health Statistics"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB8|cit8","first-page":"1391","volume-title":"Textbook of Dermatology","author":"Camp","year":"1992"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB9|cit9","first-page":"2927","volume-title":"Textbook of Dermatology","author":"Hay","year":"1992"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB10|cit10","first-page":"2961","volume-title":"Textbook of Dermatology","author":"Breathnach","year":"1992"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB11|cit11","first-page":"3037","volume-title":"Textbook of Dermatology","author":"Griffiths","year":"1992"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB12|cit12","first-page":"163","volume-title":"Topical Corticosteroids","author":"Robertson","year":"1992"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB13|cit13","first-page":"196","volume-title":"Topical Corticosteroids","author":"Sillevis Smitt","year":"1992"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB14|cit14","first-page":"589","volume-title":"Textbook of Dermatology","author":"Champion","year":"1992"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2133.1989.tb07790.x","article-title":"Long-term cyclosporin for psoriasis","volume":"120","author":"Griffiths","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2133.1992.tb00112.x","article-title":"Consensus conference on cyclosporin A for psoriasis, February 1992","volume":"126","author":"Mihatsch","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(91)90134-B","article-title":"Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis","volume":"338","author":"Sowden","year":"1991","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.1986.tb04070.x","article-title":"Short-term use of cyclosporin A in severe psoriasis","volume":"114","author":"Joost","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0140-6736(87)92829-7","article-title":"Topical cyclosporin and psoriasis (letter)","volume":"i","author":"Griffiths","year":"1987","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2133.1992.tb08035.x","article-title":"Vitamin D analogues and psoriasis","volume":"127","author":"Berth Jones","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12345542","article-title":"Clearing of psoriasis by a novel immunosuppressive macrolide","volume":"106","author":"Rappersberger","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/1523-1747.ep12456939","article-title":"Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases","volume":"98","author":"Meingassner","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00007890-197009000-00007","article-title":"Simonsen M. A lymph node assay for the graft-versus-host activity of rat lymphoid cells","volume":"10","author":"Ford","year":"1979","journal-title":"Transplantation"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1001\/jama.1986.03380220076026","article-title":"Cyclosporin improves psoriasis in a double-blind study","volume":"256","author":"Ellis","year":"1986","journal-title":"JAMA"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/bmj.293.6549.731","article-title":"Clearance of psoriasis with low dose cyclosporin","volume":"293","author":"Griffiths","year":"1986","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archderm.1987.01660260034008","article-title":"Efficacy of low-dose cyclosporine in severe atopic skin disease (letter)","volume":"123","author":"Joost","year":"1987","journal-title":"Arch Dermatol"},{"issue":"Suppl. 36","key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2133.1990.tb02881.x","article-title":"Cyclosporin A in atopic dermatitis","volume":"122","author":"Ross","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0923-1811(91)90015-P","article-title":"Oral cyclosporin inhibits the expression of contact hypersensitivity in man","volume":"2","author":"Higgins","year":"1991","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0733-8635(18)30385-1","article-title":"A review and update of the clinical uses of cyclosporine in dermatology","volume":"9","author":"Groisser","year":"1991","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2340\/0001555572321326","article-title":"The enigma of cyclosporin A treatment for psoriasis: systemic efficacy vs. topical non-responsiveness. A review","volume":"72","author":"Mrowietz","year":"1992","journal-title":"Acta Derm Venereol (Stock)"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000247460","article-title":"Clinical controversy on the effect of topical ciclosporin: what is the target site","volume":"185","author":"Surber","year":"1992","journal-title":"Dermatology"},{"issue":"Suppl. 144","key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB32|cit32","first-page":"136","article-title":"Randomised double-blind placebo-controlled trial of local cyclosporin in atopic dermatitis","author":"Prost","year":"1989","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2340\/0001555571452454","article-title":"Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis","volume":"71","author":"Rie","year":"1991","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB34|cit34","first-page":"599","article-title":"Topical activity of the immunosuppressive macrolide SDZ 281-240 in animal models of allergic contact dermatitis (abstract)","volume":"102","author":"Meingassner","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB35|cit35","first-page":"170","volume-title":"Topical Corticosteroids","author":"Marks","year":"1992"},{"key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB36|cit36","first-page":"1763","volume-title":"Textbook of Dermatology","author":"Burton","year":"1992"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB37|cit37","first-page":"5243","article-title":"SDZ ASM 981 - a novel antiinflammatory macrolactam - does not induce skin atrophy","volume":"38","author":"Meingassner","year":"1997","journal-title":"Australasian J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB38|cit38","first-page":"2056","article-title":"Topical treatment with the anti-inflammatory macrolactam SDZ ASM 981 suppresses plaque-type psoriasis","volume":"38","author":"Mrowietz","year":"1997","journal-title":"Australasian J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB39|cit39","first-page":"4134","article-title":"Topical treatment with the macrolactam SDZ ASM 981 is effective in atopic dermatitis","volume":"38","author":"Leent","year":"1997","journal-title":"Australasian J Dermatol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2133.1997.tb03788.x-BIB40|cit40","first-page":"3039","article-title":"Topical treatment with the anti-inflammatory macrolactam SDZ ASM 981 inhibits established nickel contact dermatitis","volume":"38","author":"Queille-Roussel","year":"1997","journal-title":"Australasian J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.1997.tb03788.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.1997.tb03788.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.1997.tb03788.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T12:46:14Z","timestamp":1707050774000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/137\/4\/568\/6682485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.1997.tb03788.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[1997,10]]}}}